More on CMPX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.4 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Compass Therapeutics, Inc (NQ:CMPX)
Delayed: 2.07 -0.11 (5.05%)
Prev. Close $2.18  
Open$2.17 
52 Wk High$ 
52 Wk Low$ 
Day High$2.17 
Day Low$2.06 
P/E N/A  
EPS$ 
Volume1,103,299 

Friends, Peers and Foes (?): ABBV, AMGN, ARGX, ARWR, AVTX (more...)

Aug 14, 2026 04:00 PM Form SCHEDULE 13G/A Compass Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
Aug 7, 2026 09:13 AM Form SCHEDULE 13G Compass Therapeutics, Filed by: STATE STREET CORP
Aug 7, 2026 07:48 AM Compass Therapeutics (CMPX) PT Raised to $6 at Piper Sandler
Aug 6, 2026 08:01 AM Form 10-Q Compass Therapeutics, For: Jun 30
Aug 6, 2026 07:55 AM Compass Therapeutics, Inc. (CMPX) Misses Q2 EPS by 2c
Aug 6, 2026 07:30 AM Form 8-K Compass Therapeutics, For: Aug 06
Aug 6, 2026 07:30 AM Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update
Jul 21, 2026 04:49 PM Leerink Assumes Compass Therapeutics (CMPX) at Outperform
Jul 17, 2026 10:42 AM Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026
Jul 1, 2026 05:01 PM Form 8-K Compass Therapeutics, For: Jul 01
View All Articles

Entities mentioned with CMPX

View All Entities